Tumor surveillance-what can and should be done? Screening for recurrence of hepatocellular carcinoma after liver transplantation

Liver Transplantation

Volumn 11, Issue 11 SUPPL. 2, 2005, Pages

  Roberts, John P ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER SCREENING; CANCER SURVIVAL; CLINICAL PROTOCOL; COST EFFECTIVENESS ANALYSIS; EXPLANT; HIGH RISK PATIENT; HUMAN; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; MEDICAL LITERATURE; PATHOLOGY; PATIENT SELECTION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RECURRENCE RISK; SURGICAL TECHNIQUE; SURVIVAL TIME; TUMOR RECURRENCE;

CARCINOMA, HEPATOCELLULAR; HUMANS; INCIDENCE; LIVER NEOPLASMS; LIVER TRANSPLANTATION; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; RISK FACTORS; SURVIVAL RATE;

EID: 30444445433     PISSN: 15276465     EISSN: None     Source Type: Journal    
DOI: 10.1002/lt.20605     Document Type: Article

References (7)

1. Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996;334:693-9.
2. Yao FY, Kinkhabwala M, LaBerge JM, Bass NM, Brown R Jr, Kerlan R, et al. The impact of pre-operative loco-regional therapy on outcome after liver transplantation for hepatocellular carcinoma. Am J Transpl 2005;5:795-804.
3. Regalia E, Fassati LR, Valente U, Pulvirenti A, Damilano I, Dardano G, et al. Pattern and management of recurrent hepatocellular carcinoma after liver transplantation. J Hepatobiliary Pancreat Surg 1998;5:29-34.
4. Roayaie S, Schwartz JD, Sung MW, Emre SH, Miller CM, Gondolesi GE, et al. Recurrence of hepatocellular carcinoma after liver transplant: patterns and prognosis. Liver Transpl 2004;10:534-40.
5. Pokorny H, Gnant M, Rasoul-Rockenschaub S, Gollackner B, Steiner B, Steger G, et al. Does additional doxorubicin chemotherapy improve outcome in patients with hepatocellular carcinoma treated by liver transplantation? Am J Transplant 2005;5: 788-94.
6. Schlitt HJ, Neipp M, Weimann A, Oldhafer KJ, Schmoll E, Boeker K, et al. Recurrence patterns of hepatocellular and fibrolamellar carcinoma after liver transplantation. J Clin Oncol 1999; 17:324-331.
7. Patel D, Terrault NA, Yao FY, Bass NM, Ladabaum U. Related Articles, Links: Cost-effectiveness of hepatocellular carcinoma surveillance in patients with hepatitis C virus-related cirrhosis. Clin Gastroenterol Hepatol 2005;3:75-384.